General Information of Disease (ID: DISYCORK)

Disease Name Otitis externa
Synonyms infectious otitis externa; outer Ear infection; swimmer's ear; swimmer's Ear; otitis externa; external Ear infection
Disease Class AA00-AA13: Otitis externa
Definition
Inflammation of the anatomical structures of the outer ear and ear canal secondary to an infectious process. Bacterial etiology is most common, but fungal infection is also possible. Symptoms include erythema, edema, and pain.
Disease Hierarchy
DISQZWRX: External ear disorder
DIS8ZWQ4: Ear infection
DIS0DF0D: Post-infectious disorder
DISYCORK: Otitis externa
ICD Code
ICD-11
ICD-11: AA00-AA13
Disease Identifiers
MONDO ID
MONDO_0004795
MESH ID
D010032
UMLS CUI
C0029878
MedGen ID
10505
HPO ID
HP:0410017
SNOMED CT ID
3135009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Cetraxal Otic DMX9K3W Phase 3 NA [1]
FST-201 DM1YVLM Phase 3 NA [2]
DPK 060 DMSUSMU Phase 2 Peptide [3]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
FST-200 DMC5AJO Investigative NA [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010 May 28;17(5):421-33.
2 ClinicalTrials.gov (NCT00945646) FST-201 In The Treatment of Acute Fungal Otitis Externa. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT01447017) A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis. U.S. National Institutes of Health.
4 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
5 Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64.